-
Japan approves Pfizer-BioNTech’s Covid-19 vaccine for children
Pharmaceutical-Technology
January 24, 2022
The vaccine doses that will be administered for children will use one-third of a dose given for adults.
-
The cellular response that protects pigs from COVID-19
WorldPharmaNews
January 24, 2022
Iowa State University scientists may have uncovered an important clue that sheds light on why pigs don’t get sick when exposed to the coronavirus.
-
FDA May Limit Use of Two COVID-19 Antibody Treatments
drugs.com
January 24, 2022
The U.S. Food and Drug Administration may soon curtail the use of two monoclonal antibody treatments...
-
England to Lift Travel Restrictions for Vaccinated Visitors
drugs.com
January 24, 2022
COVID-19 testing requirements for vaccinated people arriving in England will be scrapped, British Prime Minister Boris Johnson announced Monday.
-
MNA Nurses and Healthcare Professionals Call for Urgent Action from Governor Baker on 14 Critical COVID-19 Safety Recommendations
prnewswire
January 21, 2022
In a letter sent on Thursday morning to Gov. Charlie Baker, the Massachusetts Nurses Association asked the governor to take immediate action to safeguard frontline caregivers...
-
Global BFSI Industry Digital Trends Amid COVID-19 in 2022, Based on an Online Survey of 429 IT Decision-makers
prnewswire
January 21, 2022
The "Digital Trends in the BFSI Industry Amidst COVID-19 and Beyond" report has been added to ResearchAndMarkets.com's offering.
-
Australian TGA grants approval to two oral medicines for Covid-19
Pharmaceutical-Technology
January 21, 2022
The Australian Therapeutic Goods Administration (TGA) has provisionally approved the use of two oral Covid-19 treatments, Merck Sharp & Dohme’s Lagevrio (molnupiravir) and Pfizer’s Paxlovid (nirmatrelvir and ritonavir).
-
LaBelforte launches business entities for Covid-19 nasal products development
Pharmaceutical-Technology
January 21, 2022
The intranasal/inhalation products, which boost mucosal immunity, may advance the control of the disease.
-
Bill & Melinda Gates Foundation and Wellcome pledge $300 million to CEPI for COVID-19 pandemic response
ExpressPharma
January 21, 2022
The foundations call on world leaders to support the Coalition for Epidemic Preparedness Innovations (CEPI) to help end the COVID-19 crisis, prepare for future pandemics, and address epidemic threats...
-
Scandi pharma: Swede deal for Psyros Diagnostics
pharmatimes
January 21, 2022
Psyros Diagnostics has signed an agreement to be acquired by the Swedish company, Prolight Diagnostics AB. Psyros’s...